BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2367328)

  • 1. Pharmaceutical usefulness of hydroxypropylcyclodextrins: "e pluribus unum" is an essential feature.
    Rao CT; Fales HM; Pitha J
    Pharm Res; 1990 Jun; 7(6):612-5. PubMed ID: 2367328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amorphous water-soluble cyclodextrin derivatives: 2-hydroxyethyl, 3-hydroxypropyl, 2-hydroxyisobutyl, and carboxamidomethyl derivatives of beta-cyclodextrin.
    Irie T; Fukunaga K; Yoshida A; Uekama K; Fales HM; Pitha J
    Pharm Res; 1988 Nov; 5(11):713-7. PubMed ID: 3247276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of hydroxypropyl- and hydroxyethyl-derivatized beta-cyclodextrins for the thin-layer chromatographic separation of enantiomers and diastereomers.
    Armstrong DW; Faulkner JR; Han SM
    J Chromatogr; 1988 Oct; 452():323-30. PubMed ID: 3243848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxypropylcyclodextrins in parenteral use. I: Lipid dissolution and effects on lipid transfers in vitro.
    Irie T; Fukunaga K; Pitha J
    J Pharm Sci; 1992 Jun; 81(6):521-3. PubMed ID: 1522487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of substituents in 2-hydroxypropyl ethers of cyclomaltoheptaose.
    Pitha J; Rao CT; Lindberg B; Seffers P
    Carbohydr Res; 1990 Apr; 200():429-35. PubMed ID: 2379216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthesis of an active derivative of cyclomaltoheptaose for the hydrolysis of esters and the formation of amide bonds.
    Ekberg B; Andersson LI; Mosbach K
    Carbohydr Res; 1989 Oct; 192():111-7. PubMed ID: 2611774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol.
    Loftsson T; Bodor N
    Acta Pharm Nord; 1989; 1(4):185-94. PubMed ID: 2590460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of a phenytoin beta-cyclodextrin complex and evaluation of a suspension and a tablet dosage form prepared from the complex.
    Hegde RP; Rhodes CT
    Pharm Acta Helv; 1985; 60(2):53-7. PubMed ID: 3991746
    [No Abstract]   [Full Text] [Related]  

  • 9. Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine.
    Yoshida A; Yamamoto M; Itoh T; Irie T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):176-9. PubMed ID: 2337940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclodextrin derivation and amorphous state of complex on accelerated degradation of ziprasidone.
    Hong J; Shah JC; Mcgonagle MD
    J Pharm Sci; 2011 Jul; 100(7):2703-16. PubMed ID: 21283987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppositories containing cyclodextrin complexes. Part 2: Dissolution and absorption studies.
    Szente L; Apostol I; Gerlóczy A; Szejtli J
    Pharmazie; 1985 Jun; 40(6):406-7. PubMed ID: 4034649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of griseofulvin with cyclodextrins in solid binary systems.
    Veiga MD; Díaz PJ; Ahsan F
    J Pharm Sci; 1998 Jul; 87(7):891-900. PubMed ID: 9649360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the interaction of clobazam with cyclodextrins in solution and in the solid state.
    Nakai Y; el-Said Aboutaleb A; Yamamoto K; Saleh SI; Ahmed MO
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):728-32. PubMed ID: 2347015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution.
    Iohara D; Hirayama F; Ishiguro T; Arima H; Uekama K
    Int J Pharm; 2008 Apr; 354(1-2):70-6. PubMed ID: 18093762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of roll mixing with beta-cyclodextrin on enhancing solubilities of water insoluble drugs.
    Nozawa Y; Yamamoto A
    Pharm Acta Helv; 1989; 64(1):24-9. PubMed ID: 2717647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dissolution profiles of powdered inclusion compounds of sulfonamide drugs with beta-cyclodextrin].
    Chen JY; Tsai WY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Apr; 5(4):206-11. PubMed ID: 2769826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aging on crystallization, dissolution and absorption characteristics of amorphous tolbutamide-2-hydroxypropyl-beta-cyclodextrin complex.
    Kimura K; Hirayama F; Arima H; Uekama K
    Chem Pharm Bull (Tokyo); 2000 May; 48(5):646-50. PubMed ID: 10823700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of 2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizing excipient for protein drugs.
    Brewster ME; Hora MS; Simpkins JW; Bodor N
    Pharm Res; 1991 Jun; 8(6):792-5. PubMed ID: 2062811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of diethyl-beta-cyclodextrin as a sustained-release carrier for isosorbide dinitrate.
    Hirayama F; Hirashima N; Abe K; Uekama K; Ijitsu T; Ueno M
    J Pharm Sci; 1988 Mar; 77(3):233-6. PubMed ID: 3373427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregation of amphotericin B in the presence of gamma-cyclodextrin.
    Kajtár M; Vikmon M; Morlin E; Szejtli J
    Biopolymers; 1989 Sep; 28(9):1585-96. PubMed ID: 2775849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.